195 related articles for article (PubMed ID: 26913858)
1. Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?
Veerasakul S; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
Hum Psychopharmacol; 2016 May; 31(3):243-6. PubMed ID: 26913858
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers.
Hosak L; Preiss M; Bazant J; Tibenska A; Cermakova R; Cermakova E
Psychiatr Danub; 2012 Jun; 24(2):188-93. PubMed ID: 22706418
[TBL] [Abstract][Full Text] [Related]
3. Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
Hajheidari S; Miladi-Gorji H; Bigdeli I
Neurosci Lett; 2015 Jan; 584():151-5. PubMed ID: 25459292
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
Proebstl L; Kamp F; Koller G; Soyka M
Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
[TBL] [Abstract][Full Text] [Related]
5. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
[TBL] [Abstract][Full Text] [Related]
6. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
7. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
[TBL] [Abstract][Full Text] [Related]
8. Effect of methamphetamine dependence on everyday functional ability.
Henry BL; Minassian A; Perry W
Addict Behav; 2010 Jun; 35(6):593-8. PubMed ID: 20167435
[TBL] [Abstract][Full Text] [Related]
9. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492
[TBL] [Abstract][Full Text] [Related]
11. Patterns of methamphetamine abuse and their consequences.
Cho AK; Melega WP
J Addict Dis; 2002; 21(1):21-34. PubMed ID: 11831497
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
[TBL] [Abstract][Full Text] [Related]
13. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Assessment of the Effects of HIV and Methamphetamine Dependence on Socially Dysregulated Behavior in the Human Behavioral Pattern Monitor.
Miranda A; Perry W; Umlauf A; Young JW; Morgan EE; Minassian A;
AIDS Behav; 2023 Aug; 27(8):2617-2628. PubMed ID: 36738342
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
[TBL] [Abstract][Full Text] [Related]
16. Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.
Cadet JL; Krasnova IN
Neurotox Res; 2007 Oct; 12(3):181-204. PubMed ID: 17967742
[TBL] [Abstract][Full Text] [Related]
17. Meth mouth.
Heng CK; Badner VM; Schiop LA
N Y State Dent J; 2008; 74(5):50-1. PubMed ID: 18982966
[TBL] [Abstract][Full Text] [Related]
18. Meth mouth severity in response to drug-use patterns and dental access in methamphetamine users.
Brown RE; Morisky DE; Silverstein SJ
J Calif Dent Assoc; 2013 Jun; 41(6):421-8. PubMed ID: 23875434
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine abuse and oral health: a pilot study of "meth mouth".
Ravenel MC; Salinas CF; Marlow NM; Slate EH; Evans ZP; Miller PM
Quintessence Int; 2012 Mar; 43(3):229-37. PubMed ID: 22299123
[TBL] [Abstract][Full Text] [Related]
20. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
van Gorp WG; Hinkin CH
Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
